- Home
- WFCF vs NRXP Comparison
WFCF vs NRXP Comparison
Compare WFCF & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WFCF | NRXP |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1M | 73.7M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | WFCF | NRXP |
|---|---|---|
| Price | $12.67 | $2.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $30.50 |
| AVG Volume (30 Days) | 3.8K | ★ 446.3K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.82 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $25,512,000.00 | $242,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $643.59 |
| P/E Ratio | $24.18 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.26 | $1.15 |
| 52 Week High | $13.78 | $6.01 |
Technical Indicators
Market Signals| Indicator | WFCF | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 45.23 |
| Support Level | $12.50 | $2.22 |
| Resistance Level | $13.15 | $2.51 |
| Average True Range (ATR) | 0.41 | 0.19 |
| MACD | 0.12 | 0.04 |
| Stochastic Oscillator | 79.18 | 68.52 |
Price Performance
Historical ComparisonAbout WFCF Where Food Comes From Inc.
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.